 |
|
|
| |
SWORD-1 & SWORD-2: Subgroup Analysis of 48-Week Results by Age, Race and Gender
|
| |
| |
Reported by Jules Levin
IDWeek2017/IDSA, October 4-8, 2017, San Diego
S Walmsley,1G Richmond,2F Bredeek,3M Ramgopal,4C-C Hung,5E Blair,6L Kahl,7M Underwood,6K Angelis,8K Vandermeulen,9B Wynne,10M Aboud7
1University Health Network, Toronto, Ontario, Canada; 2Holy Cross Hospital, Fort Lauderdale, FL; 3Maple Leaf Research, Toronto, Ontario, Canada; 4Midway Immunology and Research Center, Fort Pierce, FL; 5Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei,Taiwan; 6ViiV Healthcare, Research Triangle Park, NC; 7ViiV Healthcare, Brentford, UK; 8GlaxoSmithKline, Uxbridge, UK; 9Janssen, Beerse, Belgium; 10ViiV Healthcare, Collegeville, PA
|
| |
|
|
|
|
|
